IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT J RUFFNER

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1871531632
CMS profile
311154
Location
PITTSBURGH, PA

General Payments · PY2018–2024

$7,602.64

  • Reported across 453 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$988.83

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $988.83 51

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
E.R. Squibb & Sons, L.L.C. $245.87 12
NOVARTIS PHARMACEUTICALS CORPORATION $202.16 13
Boehringer Ingelheim Pharmaceuticals, Inc. $125.12 6
Amgen Inc. $116.92 6
Kiniksa Pharmaceuticals International, plc $114.93 5
Merck Sharp & Dohme Corporation $100.51 5
Acerta Pharma LLC $57.58 3
PFIZER INC. $25.74 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $962.62 65
PY2019 $1,090.49 78
PY2020 $924.45 57
PY2021 $992.29 62
PY2022 $1,308.28 70
PY2023 $1,335.68 70
PY2024 $988.83 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $19.09 01/24/2024 Food and Beverage Undisputed 01/23/2026 1116072921 CMS
Amgen Inc. $16.17 02/27/2024 Food and Beverage Undisputed 01/23/2026 1116072927 CMS
Amgen Inc. $17.36 03/12/2024 Food and Beverage Undisputed 01/23/2026 1116072935 CMS
Amgen Inc. $21.97 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116072941 CMS
Amgen Inc. $22.09 07/31/2024 Food and Beverage Undisputed 01/23/2026 1116072948 CMS
Amgen Inc. $20.24 10/22/2024 Food and Beverage Undisputed 01/23/2026 1116072955 CMS
AstraZeneca Pharmaceuticals LP $17.55 03/20/2024 Food and Beverage Undisputed 01/23/2026 1105653362 CMS
AstraZeneca Pharmaceuticals LP $19.98 09/10/2024 Food and Beverage Undisputed 01/23/2026 1104353640 CMS
AstraZeneca Pharmaceuticals LP $20.05 10/29/2024 Food and Beverage Undisputed 01/23/2026 1105408405 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.77 01/31/2024 Food and Beverage Undisputed 01/23/2026 1118201879 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.52 06/12/2024 Food and Beverage Undisputed 01/23/2026 1118201895 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $29.20 07/19/2024 Food and Beverage Undisputed 01/23/2026 1118201899 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.73 07/29/2024 Food and Beverage Undisputed 01/23/2026 1118201887 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.81 08/23/2024 Food and Beverage Undisputed 01/23/2026 1118201883 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.09 09/11/2024 Food and Beverage Undisputed 01/23/2026 1118201891 CMS
E.R. Squibb & Sons, L.L.C. $19.71 01/03/2024 Food and Beverage Undisputed 01/23/2026 1101205104 CMS
E.R. Squibb & Sons, L.L.C. $18.56 02/06/2024 Food and Beverage Undisputed 01/23/2026 1101205108 CMS
E.R. Squibb & Sons, L.L.C. $18.26 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101205110 CMS
E.R. Squibb & Sons, L.L.C. $20.76 03/06/2024 Food and Beverage Undisputed 01/23/2026 1101205112 CMS
E.R. Squibb & Sons, L.L.C. $24.60 03/20/2024 Food and Beverage Undisputed 01/23/2026 1101205122 CMS
E.R. Squibb & Sons, L.L.C. $18.26 04/29/2024 Food and Beverage Undisputed 01/23/2026 1101205126 CMS
E.R. Squibb & Sons, L.L.C. $21.54 05/15/2024 Food and Beverage Undisputed 01/23/2026 1101205128 CMS
E.R. Squibb & Sons, L.L.C. $17.62 06/05/2024 Food and Beverage Undisputed 01/23/2026 1101205130 CMS
E.R. Squibb & Sons, L.L.C. $24.47 09/04/2024 Food and Beverage Undisputed 01/23/2026 1101205140 CMS
E.R. Squibb & Sons, L.L.C. $20.16 10/23/2024 Food and Beverage Undisputed 01/23/2026 1101205146 CMS
E.R. Squibb & Sons, L.L.C. $18.82 10/28/2024 Food and Beverage Undisputed 01/23/2026 1101205154 CMS
E.R. Squibb & Sons, L.L.C. $23.11 12/04/2024 Food and Beverage Undisputed 01/23/2026 1101205162 CMS
Kiniksa Pharmaceuticals International, plc $24.17 01/17/2024 Food and Beverage Undisputed 01/23/2026 1154873522 CMS
Kiniksa Pharmaceuticals International, plc $21.62 02/14/2024 Food and Beverage Undisputed 01/23/2026 1154873542 CMS
Kiniksa Pharmaceuticals International, plc $22.97 03/18/2024 Food and Beverage Undisputed 01/23/2026 1154873556 CMS
Kiniksa Pharmaceuticals International, plc $21.83 04/24/2024 Food and Beverage Undisputed 01/23/2026 1154873594 CMS
Kiniksa Pharmaceuticals International, plc $24.34 09/16/2024 Food and Beverage Undisputed 01/23/2026 1154873660 CMS
Merck Sharp & Dohme LLC $18.33 01/09/2024 Food and Beverage Undisputed 01/23/2026 1141766800 CMS
Merck Sharp & Dohme LLC $21.95 06/04/2024 Food and Beverage Undisputed 01/23/2026 1141766798 CMS
Merck Sharp & Dohme LLC $20.22 07/10/2024 Food and Beverage Undisputed 01/23/2026 1141766626 CMS
Merck Sharp & Dohme LLC $21.13 08/28/2024 Food and Beverage Undisputed 01/23/2026 1141939513 CMS
Merck Sharp & Dohme LLC $18.88 11/18/2024 Food and Beverage Undisputed 01/23/2026 1141766638 CMS
Novartis Pharmaceuticals Corporation $20.65 01/10/2024 Food and Beverage Undisputed 01/23/2026 1087244251 CMS
Novartis Pharmaceuticals Corporation $16.76 02/05/2024 Food and Beverage Undisputed 01/23/2026 1087244269 CMS
Novartis Pharmaceuticals Corporation $19.83 03/04/2024 Food and Beverage Undisputed 01/23/2026 1087244279 CMS
Novartis Pharmaceuticals Corporation $17.99 05/14/2024 Food and Beverage Undisputed 01/23/2026 1087244287 CMS
Novartis Pharmaceuticals Corporation $19.18 07/09/2024 Food and Beverage Undisputed 01/23/2026 1087244303 CMS
Novartis Pharmaceuticals Corporation $16.45 08/06/2024 Food and Beverage Undisputed 01/23/2026 1087244315 CMS
Novartis Pharmaceuticals Corporation $16.25 08/21/2024 Food and Beverage Undisputed 01/23/2026 1087244317 CMS
Novartis Pharmaceuticals Corporation $24.06 09/23/2024 Food and Beverage Undisputed 01/23/2026 1087244333 CMS
Novartis Pharmaceuticals Corporation $5.62 10/01/2024 Food and Beverage Undisputed 01/23/2026 1087244335 CMS
Novartis Pharmaceuticals Corporation $20.88 10/15/2024 Food and Beverage Undisputed 01/23/2026 1087244337 CMS
Novartis Pharmaceuticals Corporation $4.68 11/05/2024 Food and Beverage Undisputed 01/23/2026 1087244339 CMS
Novartis Pharmaceuticals Corporation $15.69 12/09/2024 Food and Beverage Undisputed 01/23/2026 1087244361 CMS
Novartis Pharmaceuticals Corporation $4.12 12/17/2024 Food and Beverage Undisputed 01/23/2026 1087244365 CMS
PFIZER INC. $25.74 11/05/2024 Food and Beverage Undisputed 01/23/2026 1131071557 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.